|
MIRM | Mirum Pharmaceuticals, Inc. |
|
|
MIRM | Mirum Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.29 |
| Leverage | 66.31% |
| Market Cap | $ 2.3B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -77.1m |
| Margin | -20.30% |
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.